查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球植入式心臟整流去颤器市场规模、份额、行业趋势分析报告：按类型、产品类型、NYHA 类别、最终用途、区域展望和预测，2023-2030 年
市场调查报告书
商品编码
1384832

全球植入式心臟整流去颤器市场规模、份额、行业趋势分析报告：按类型、产品类型、NYHA 类别、最终用途、区域展望和预测，2023-2030 年

Global Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Regional Outlook and Forecast, 2023 - 2030
出版日期: | 出版商: KBV Research | 英文 286 Pages | 订单完成后即时交付

价格

植入式心臟整流去颤器市场规模预计到 2030 年将达到 56 亿美元，预测期内年复合成长率年增长率为 6.1%。

然而，ICD 的高昂费用可能会给一些患者带来经济障碍，尤其是那些保险不足或居住在医疗保健服务有限的地区的患者。社会经济差异和获得医疗保健的机会差异可能会影响接受 ICD 治疗的人。一些弱势群体在使用ICD方面面临更大的挑战。在农村和服务不足的地区，使用专门的医疗保健设施和训练有素的心臟电生理学家来进行 ICD 植入的机会有限。地理差异影响 ICD 治疗的可近性。植入式心臟整流去颤器的成本和可用性是医疗保健环境中的重要议题。

此外，在大流行的早期阶段，许多医院和医疗机构推迟了选择性治疗，包括 ICD 植入，并优先考虑 COVID-19 患者以节省资源。这导致一些地区ICD植入率下降。此次疫情加速了 ICD 远端监控技术的采用。由于亲自就诊受到限製或不鼓励，医疗保健提供者越来越依赖远端监控来评估设备功能和患者状态。这一趋势在大流行后持续存在，患者照护的弹性增加。虽然此类服务并未取代面对面治疗，但在患者监测和管理方面发挥了作用。 COVID-19 对市场产生了中等影响。

类型展望

依类型分为单室ICD、双室ICD和双室ICD。在 2022 年的市场中，双腔 ICD 占了很大的收益占有率。双腔 ICD 的优点是能够监测心房和心室，从而实现更复杂的心律不整检测演算法。这种检测能力的增强可以减少不适当的电击并改善患者的治疗结果。许多双腔 ICD 都具有心房和心室起搏功能。此功能对于需要生理节律以维持适当心臟功能的患者有益，例如房室传导阻滞或病态窦房结症候群。

产品类型展望

依产品类型划分，市场分为静脉注射和皮下注射。 2022年，静脉注射剂型占市场最高销售份额。经静脉 ICD 适用于许多患者，包括因各种心臟疾病而有心臟麻痹风险的患者。这种广泛的患者适应症扩大了该设备的潜在市场。经静脉 ICD 技术的不断进步正在开发更小、更强大的设备，这些设备具有更长的电池寿命和先进的心律不整检测演算法。这些进步使得经静脉 ICD 对患者和医疗保健提供者更具吸引力。

NYHA 班级展望

依NYHA等级，市场可分为NYHA II级和NYHA III级。在 2022 年市场中，NYHA III 级占据了重要的收益占有率。 ICD植入的主要适应症之一是降低室性心律不整高风险心室心律不整患者的心臟衰竭猝死风险。具有某些危险因子（例如低左心室射血分数（LVEF）或心室心律不整病史）的 NYHA III 级患者可考虑进行 ICD 治疗以预防 SCD。

最终用途展望

根据最终用途，市场分为医院、门诊手术中心等。 2022年，医院细分市场收益占有率最大。医院为 ICD 植入手术提供受控的无菌环境，确保最高水准的病患照护和安全。该医院拥有心臟电生理学家和心臟团队，他们在 ICD 植入、编程和后续护理方面接受过广泛的培训和专业知识。各大医院都配备了最先进的设备，包括先进的心导管实验室和手术室，这对于 ICD 植入手术至关重要。

区域展望

从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲/中东/非洲的市场进行了分析。 2022年，北美地区以最高的收益占有率引领市场。北美的医疗保健、诊所和其他医疗设施正在发展和现代化。此外，该地区高血压等心血管疾病（CVD）的盛行率很高，因此需要植入式心臟去颤器（ICD）。美敦力（Medtronic）、雅培（Abbott）、波士顿科学公司（Boston Scientific Corporation）等主要製造商正在进一步整合市场，其中美敦力（Medtronic）推出血管外ICD（EV-ICD），带来了巨大的商机。此外，中国、印度和日本企业正在积极开发和推出创新的医疗保健解决方案，推动区域市场的发展。

目录

第1章市场范围和调查方法

  • 市场定义
  • 目的
  • 市场范围
  • 分割
  • 调查方法

第2章市场概况

  • 主要亮点

第3章市场概况

  • 介绍
    • 概述
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场抑制因素
  • 波特五力分析

第4章植入式心臟整流去颤器市场发展策略

第5章全球植入式心臟整流去颤器市场：按类型

  • 全球双心室设备市场：按地区
  • 全球双腔 ICD 市场：按地区
  • 全球单腔 ICD 市场：按地区

第6章世界市场：依产品类型

  • 全球静脉注射市场：按地区划分
  • 全球皮下市场：按地区

第7章世界市场，依 NYHA 等级

  • 全球 NYHA II 级市场：按地区
  • 全球 NYHA III 级市场：按地区

第8章全球市场：依最终用途分类

  • 全球医院市场：按地区
  • 全球门诊手术中心市场：按地区
  • 世界其他市场：按地区

第9章世界市场：按地区

  • 北美市场
    • 北美市场：按类型
      • 北美双心室装置市场（按国家）
      • 北美双腔 ICD 市场（按国家）
      • 北美单腔 ICD 市场（按国家）
    • 北美市场：依产品类型
      • 北美静脉注射市场（按国家划分）
      • 北美皮下注射市场（按国家划分）
    • 北美市场 NYHA 级
      • 北美国家 NYHA II 级市场
      • 北美国家 NYHA III 级市场
    • 北美市场：依最终用途分类
      • 北美医院市场（按国家）
      • 北美门诊手术中心市场（按国家）
      • 北美及其他国家市场
    • 北美市场：按国家划分
      • 美国植入式心臟整流去颤器市场
      • 加拿大植入式心臟整流去颤器市场
      • 墨西哥植入式心臟整流去颤器市场
      • 其他北美市场
  • 欧洲市场
    • 欧洲市场：按类型分类
      • 按国家分類的欧洲双心室装置市场
      • 欧洲双腔 ICD 市场（按国家）
      • 欧洲单腔 ICD 市场（按国家）
    • 欧洲市场：按产品类型
      • 欧洲静脉注射市场（按国家划分）
      • 欧洲皮下市场（按国家划分）
    • 欧洲市场 NYHA 按类别
      • 欧洲 NYHA II 级市场（按国家）
      • 欧洲 NYHA III 级市场（按国家/地区）
    • 欧洲市场：依最终用途分类
      • 欧洲医院市场（按国家）
      • 欧洲门诊手术中心市场：（依国家划分）
      • 欧洲其他市场
    • 欧洲市场：依国家分类
      • 德国植入式心臟整流去颤器市场
      • 英国植入式心臟整流去颤器市场
      • 法国植入式心臟整流去颤器市场
      • 俄罗斯植入式心臟整流去颤器市场
      • 西班牙植入式心臟整流去颤器市场
      • 义大利植入式心臟整流去颤器市场
      • 其他欧洲市场
  • 亚太市场
    • 亚太市场：依类型
      • 亚太地区双心室设备市场：（依国家）
      • 亚太地区双腔 ICD 市场（按国家）
      • 亚太地区各国单腔 ICD 市场
    • 亚太市场：依产品类型
      • 按国家分類的亚太静脉注射市场
      • 亚太地区皮下注射市场（依国家划分）
    • 亚太市场 NYHA 类别
      • 亚太地区 NYHA II 级市场（按国家/地区）
      • 亚太地区 NYHA III 级市场（按国家/地区划分）
    • 亚太市场：依最终用途分类
      • 亚太地区医院市场（按国家）
      • 亚太地区门诊手术中心市场：（按国家/地区）
      • 亚太其他国家市场
    • 亚太市场：依国家分类
      • 中国植入式心臟整流去颤器市场
      • 日本植入式心臟整流去颤器市场
      • 印度植入式心臟整流去颤器市场
      • 韩国植入式心臟整流去颤器市场
      • 新加坡植入式心臟整流去颤器市场
      • 马来西亚植入式心臟整流去颤器市场
      • 其他亚太市场
  • 拉丁美洲/中东/非洲市场
    • 拉丁美洲/中东/非洲市场：按类型
      • 拉丁美洲、中东和非洲国家双心室装置市场
      • 拉丁美洲、中东和非洲各国双腔 ICD 市场
      • 拉丁美洲、中东和非洲各国单腔 ICD 市场
    • 拉丁美洲/中东/非洲市场：依产品类型
      • 拉丁美洲、中东和非洲各国的静脉市场
      • 拉丁美洲、中东和非洲各国皮下市场
    • 以 NYHA 等级分類的拉丁美洲/中东/非洲市场
      • 拉丁美洲、中东和非洲国家 NYHA II 级市场
      • 拉丁美洲、中东和非洲国家 NYHA III 级市场
    • 拉丁美洲/中东/非洲市场：依最终用途分类
      • 拉丁美洲、中东和非洲国家医院市场
      • 拉丁美洲、中东和非洲国家门诊手术中心市场
      • 拉丁美洲、中东和非洲按国家分類的其他市场
    • 拉丁美洲/中东/非洲市场：依国家分类
      • 巴西植入式心臟整流去颤器市场
      • 阿根廷植入式心臟整流去颤器市场
      • 阿联酋植入式心臟整流去颤器市场
      • 沙乌地阿拉伯植入式心臟整流去颤器市场
      • 南非植入式心臟整流去颤器市场
      • 尼日利亚植入式心臟整流去颤器市场
      • 其他拉丁美洲/中东/非洲市场

第10章公司简介

  • Abbott Laboratories
  • Medtronic PLC
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • ZOLL Medical Corporation（Asahi Kasei Corporation）
  • LivaNova PLC
  • Koninklijke Philips NV
  • Getinge AB

第11章植入式心臟整流去颤器市场获胜先决条件

The Global Implantable Cardioverter Defibrillator Market size is expected to reach $5.6 billion by 2030, rising at a market growth of 6.1% CAGR during the forecast period.

The rising incidence of cardiovascular diseases, like heart failure and arrhythmias, contributes to the growing demand for ICDs. Therefore, Dual Chamber ICDs segment would generate $1,164.3 million revenue in the market in 2022. As the global population ages and lifestyle-related risk factors continue to rise, the prevalence of these conditions is expected to increase. CVD, including coronary artery disease and heart failure, is often associated with an increased risk of arrhythmias, including ventricular tachycardia (VT) and ventricular fibrillation (VF). Some of the factors impacting the market are expansion of indications for ICDs, development of MRI-compatible ICDs and high cost and limited accessibility.

Patients with ARVC at risk of ventricular arrhythmias candidates for ICD implantation. ARVC is a rare genetic disorder that affects the heart muscle and can lead to arrhythmias. Patients with inherited LQTS, associated with a higher risk of life-threatening arrhythmias, are considered for ICD therapy if they have experienced syncopal episodes or have a history of cardiac arrest. Brugada syndrome is another inherited arrhythmia disorder that can lead to sudden cardiac arrest. Additionally, the availability of MRI-compatible ICDs has significantly improved patient care by enabling individuals with ICDs to undergo essential MRI scans without needing device removal or the associated risks of potential device interactions during the scan. Additionally, the introduction of MRI-compatible ICDs expanded the ICD potential patient population. Patients often prefer Expanding indications for implantable cardioverter defibrillators (ICDs) have significantly developed the implantable cardioverter defibrillator market and the development of MRI-compatible ICDs represents a significant step forward in patient care, allowing individuals with ICDs to access essential MRI scans without compromising cardiac therapy. Thus, due to the following factors the market will expand.

However, the high cost of ICDs can create financial barriers for some patients, particularly those without adequate health insurance coverage or those living in regions with limited healthcare services. Socioeconomic disparities and disparities in healthcare access can affect who has access to ICD therapy. Some underserved populations face greater challenges in accessing ICDs. Access to specialized healthcare facilities and trained cardiac electrophysiologists who perform ICD implantation procedures are limited in rural or underserved areas. Geographic disparities can affect access to ICD therapy. The cost and accessibility of implantable cardioverter defibrillators are significant challenges in the healthcare landscape.

Furthermore, during the early stages of the pandemic, many hospitals and healthcare facilities postponed elective procedures, including ICD implantations, to prioritize COVID-19 patients and conserve resources. This led to a decline in ICD implantations in some regions. The pandemic accelerated the adoption of remote monitoring technology for ICDs. With in-person visits restricted or discouraged, healthcare providers increasingly relied on remote monitoring to assess device function and patient status. This trend continued even after the pandemic as it offered more flexibility in patient care. While these services are not a replacement for in-person procedures, they played a role in patient monitoring and management. COVID-19 had a moderate effect on the market.

Type Outlook

Based on type, the market is classified into single chamber ICDs, dual chamber ICDs, and biventricular devices. The dual chamber ICDs segment acquired a substantial revenue share in the market in 2022. Dual-chamber ICDs have the advantage of monitoring both the atrium and ventricle, which allows for more sophisticated arrhythmia detection algorithms. This improved detection capability can help reduce inappropriate shocks and improve patient outcomes. Many dual-chamber ICDs have pacing capabilities for both the atrium and ventricle. This feature can benefit patients who require physiological pacing to maintain proper heart function, such as those with atrioventricular (AV) block or sick sinus syndrome.

Product Type Outlook

By product type, the market is categorized into transvenous and subcutaneous. In 2022, the transvenous segment held the highest revenue share in the market. Transvenous ICDs suit many patients, including those at risk of sudden cardiac arrest because of various cardiac conditions. This broad patient eligibility expands the potential market for these devices. Ongoing advancements in transvenous ICD technology have led to smaller, more sophisticated devices with improved battery life and advanced arrhythmia detection algorithms. These advancements make transvenous ICDs more appealing to both patients and healthcare providers.

NYHA Class Outlook

On the basis of NYHA class, the market is divided into NYHA class II and NYHA class III. The NYHA class III segment garnered a significant revenue share in the market in 2022. One of the primary indications for ICD implantation is to reduce the risk of sudden cardiac death in heart failure patients at high risk of ventricular arrhythmias. NYHA Class III patients with specific risk factors, such as a reduced left ventricular ejection fraction (LVEF) or a history of ventricular arrhythmias, are considered for ICD therapy to prevent SCD.

End-use Outlook

By end-use, the market is fragmented into hospitals, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the maximum revenue share in the market. Hospitals provide a controlled and sterile environment for ICD implantation procedures, ensuring the highest level of care and safety for patients. Hospitals have cardiac electrophysiologists and specialized cardiac teams with extensive training and expertise in ICD implantation, programming, and follow-up care. Leading hospitals have state-of-the-art facilities, including advanced cardiac catheterization labs and operating rooms, essential for ICD implantation procedures.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. Hospitals, clinics, and other healthcare facilities are well-developed and modernized in North America. Additionally, the region also experiences a high prevalence of cardiovascular diseases (CVD), such as hypertension, necessitating ICDs. The market is further strengthened by significant manufacturers like Medtronic, Abbott, and Boston Scientific Corporation, with Medtronic's launch of extravascular ICDs (EV-ICDs) presenting substantial opportunities. In addition, companies in China, India, and Japan are actively developing and introducing innovative healthcare solutions, driving the development of the regional market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Stryker Corporation, ZOLL Medical Corporation (Asahi Kasei Corporation), LivaNova PLC, Koninklijke Philips N.V. and Getinge AB.

Strategies Deployed in Implantable Cardioverter Defibrillator Market

Jul-2023: Abbott Laboratories got approval from the FDA for the AVEIR dual chamber (DR) leadless pacemaker system, an advanced medical device that offers dual-chamber pacing capabilities without the need for traditional leads or wires, improving patient comfort and reducing potential complications.

Nov-2021: Koninklijke Philips N.V. acquired Cardiology, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Through his acquisition, Koninklijke Philips N.V. would be able to strengthen its diagnostics offering and cardiac monitoring with electrocardiogram (ECG) analysis, creative software technology, and reporting services.

Apr-2021: ZOLL Medical Corporation took over Respicardia, Inc., a medical device company focused on developing innovative therapies for people with central sleep apnea. Through this acquisition, both companies jointly worked together to enhance patient outcomes through the development of groundbreaking therapies for conditions with significant unmet clinical needs.

Feb-2021: Koninklijke Philips N.V. took over BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. Through this acquisition, Koninklijke Philips N.V. would be in a favourable position to enhance patient care across care environments for medical conditions and numerous diseases with the help of the combination of both the organization's portfolio and service platforms.

Oct-2020: Abbott Laboratories introduced ICD (Implantable Cardioverter-Defibrillator), a medical device that monitors heart rhythms and delivers shocks to treat life-threatening arrhythmias, and CRT-D (Cardiac Resynchronization Therapy with Defibrillation), an ICD with an added feature to synchronize the contractions of the heart's ventricles, improving heart function in certain patients.

Apr-2019: Stryker Corporation launched LIFEPAK® CR2 Defibrillator in the United States, an advanced automated external defibrillator (AED) designed for easy use in emergency cardiac situations. The LIFEPAK CR2 is designed to improve CPR quality and deliver the quickest initial shock during defibrillation, with every aspect tailored to boost user confidence, utilizing connectivity to support comprehensive care in the chain of survival and streamline AED program management for our clients.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Biventricular Devices
  • Dual Chamber ICDs
  • Single Chamber ICDs

By Product Type

  • Transvenous
  • Subcutaneous

By NYHA Class

  • NYHA Class II
  • NYHA Class III

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Medtronic PLC
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • ZOLL Medical Corporation (Asahi Kasei Corporation)
  • LivaNova PLC
  • Koninklijke Philips N.V.
  • Getinge AB

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Implantable Cardioverter Defibrillator Market, by Type
    • 1.4.2 Global Implantable Cardioverter Defibrillator Market, by Product Type
    • 1.4.3 Global Implantable Cardioverter Defibrillator Market, by NYHA Class
    • 1.4.4 Global Implantable Cardioverter Defibrillator Market, by End-use
    • 1.4.5 Global Implantable Cardioverter Defibrillator Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Implantable Cardioverter Defibrillator Market

Chapter 5. Global Implantable Cardioverter Defibrillator Market, By Type

  • 5.1 Global Biventricular Devices Market, By Region
  • 5.2 Global Dual Chamber ICDs Market, By Region
  • 5.3 Global Single Chamber ICDs Market, By Region

Chapter 6. Global Implantable Cardioverter Defibrillator Market, By Product Type

  • 6.1 Global Transvenous Market, By Region
  • 6.2 Global Subcutaneous Market, By Region

Chapter 7. Global Implantable Cardioverter Defibrillator Market, By NYHA Class

  • 7.1 Global NYHA Class II Market, By Region
  • 7.2 Global NYHA Class III Market, By Region

Chapter 8. Global Implantable Cardioverter Defibrillator Market, By End-use

  • 8.1 Global Hospitals Market, By Region
  • 8.2 Global Ambulatory Surgical Centers Market, By Region
  • 8.3 Global Others Market, By Region

Chapter 9. Global Implantable Cardioverter Defibrillator Market, By Region

  • 9.1 North America Implantable Cardioverter Defibrillator Market
    • 9.1.1 North America Implantable Cardioverter Defibrillator Market, By Type
      • 9.1.1.1 North America Biventricular Devices Market, By Country
      • 9.1.1.2 North America Dual Chamber ICDs Market, By Country
      • 9.1.1.3 North America Single Chamber ICDs Market, By Country
    • 9.1.2 North America Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.1.2.1 North America Transvenous Market, By Country
      • 9.1.2.2 North America Subcutaneous Market, By Country
    • 9.1.3 North America Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.1.3.1 North America NYHA Class II Market, By Country
      • 9.1.3.2 North America NYHA Class III Market, By Country
    • 9.1.4 North America Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.4.1 North America Hospitals Market, By Country
      • 9.1.4.2 North America Ambulatory Surgical Centers Market, By Country
      • 9.1.4.3 North America Others Market, By Country
    • 9.1.5 North America Implantable Cardioverter Defibrillator Market, By Country
      • 9.1.5.1 US Implantable Cardioverter Defibrillator Market
        • 9.1.5.1.1 US Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.1.2 US Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.1.3 US Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.1.4 US Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.5.2 Canada Implantable Cardioverter Defibrillator Market
        • 9.1.5.2.1 Canada Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.2.2 Canada Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.2.3 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.2.4 Canada Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.5.3 Mexico Implantable Cardioverter Defibrillator Market
        • 9.1.5.3.1 Mexico Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.3.2 Mexico Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.3.3 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.3.4 Mexico Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.5.4 Rest of North America Implantable Cardioverter Defibrillator Market
        • 9.1.5.4.1 Rest of North America Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.4.2 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.4.3 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.4.4 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use
  • 9.2 Europe Implantable Cardioverter Defibrillator Market
    • 9.2.1 Europe Implantable Cardioverter Defibrillator Market, By Type
      • 9.2.1.1 Europe Biventricular Devices Market, By Country
      • 9.2.1.2 Europe Dual Chamber ICDs Market, By Country
      • 9.2.1.3 Europe Single Chamber ICDs Market, By Country
    • 9.2.2 Europe Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.2.2.1 Europe Transvenous Market, By Country
      • 9.2.2.2 Europe Subcutaneous Market, By Country
    • 9.2.3 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.2.3.1 Europe NYHA Class II Market, By Country
      • 9.2.3.2 Europe NYHA Class III Market, By Country
    • 9.2.4 Europe Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.4.1 Europe Hospitals Market, By Country
      • 9.2.4.2 Europe Ambulatory Surgical Centers Market, By Country
      • 9.2.4.3 Europe Others Market, By Country
    • 9.2.5 Europe Implantable Cardioverter Defibrillator Market, By Country
      • 9.2.5.1 Germany Implantable Cardioverter Defibrillator Market
        • 9.2.5.1.1 Germany Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.1.2 Germany Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.1.3 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.1.4 Germany Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.2 UK Implantable Cardioverter Defibrillator Market
        • 9.2.5.2.1 UK Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.2.2 UK Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.2.3 UK Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.2.4 UK Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.3 France Implantable Cardioverter Defibrillator Market
        • 9.2.5.3.1 France Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.3.2 France Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.3.3 France Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.3.4 France Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.4 Russia Implantable Cardioverter Defibrillator Market
        • 9.2.5.4.1 Russia Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.4.2 Russia Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.4.3 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.4.4 Russia Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.5 Spain Implantable Cardioverter Defibrillator Market
        • 9.2.5.5.1 Spain Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.5.2 Spain Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.5.3 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.5.4 Spain Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.6 Italy Implantable Cardioverter Defibrillator Market
        • 9.2.5.6.1 Italy Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.6.2 Italy Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.6.3 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.6.4 Italy Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.7 Rest of Europe Implantable Cardioverter Defibrillator Market
        • 9.2.5.7.1 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.7.2 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.7.3 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.7.4 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use
  • 9.3 Asia Pacific Implantable Cardioverter Defibrillator Market
    • 9.3.1 Asia Pacific Implantable Cardioverter Defibrillator Market, By Type
      • 9.3.1.1 Asia Pacific Biventricular Devices Market, By Country
      • 9.3.1.2 Asia Pacific Dual Chamber ICDs Market, By Country
      • 9.3.1.3 Asia Pacific Single Chamber ICDs Market, By Country
    • 9.3.2 Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.3.2.1 Asia Pacific Transvenous Market, By Country
      • 9.3.2.2 Asia Pacific Subcutaneous Market, By Country
    • 9.3.3 Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.3.3.1 Asia Pacific NYHA Class II Market, By Country
      • 9.3.3.2 Asia Pacific NYHA Class III Market, By Country
    • 9.3.4 Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.4.1 Asia Pacific Hospitals Market, By Country
      • 9.3.4.2 Asia Pacific Ambulatory Surgical Centers Market, By Country
      • 9.3.4.3 Asia Pacific Others Market, By Country
    • 9.3.5 Asia Pacific Implantable Cardioverter Defibrillator Market, By Country
      • 9.3.5.1 China Implantable Cardioverter Defibrillator Market
        • 9.3.5.1.1 China Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.1.2 China Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.1.3 China Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.1.4 China Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.2 Japan Implantable Cardioverter Defibrillator Market
        • 9.3.5.2.1 Japan Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.2.2 Japan Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.2.3 Japan Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.2.4 Japan Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.3 India Implantable Cardioverter Defibrillator Market
        • 9.3.5.3.1 India Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.3.2 India Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.3.3 India Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.3.4 India Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.4 South Korea Implantable Cardioverter Defibrillator Market
        • 9.3.5.4.1 South Korea Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.4.2 South Korea Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.4.3 South Korea Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.4.4 South Korea Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.5 Singapore Implantable Cardioverter Defibrillator Market
        • 9.3.5.5.1 Singapore Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.5.2 Singapore Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.5.3 Singapore Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.5.4 Singapore Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.6 Malaysia Implantable Cardioverter Defibrillator Market
        • 9.3.5.6.1 Malaysia Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.6.2 Malaysia Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.6.3 Malaysia Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.6.4 Malaysia Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.7 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market
        • 9.3.5.7.1 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.7.2 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.7.3 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.7.4 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use
  • 9.4 LAMEA Implantable Cardioverter Defibrillator Market
    • 9.4.1 LAMEA Implantable Cardioverter Defibrillator Market, By Type
      • 9.4.1.1 LAMEA Biventricular Devices Market, By Country
      • 9.4.1.2 LAMEA Dual Chamber ICDs Market, By Country
      • 9.4.1.3 LAMEA Single Chamber ICDs Market, By Country
    • 9.4.2 LAMEA Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.4.2.1 LAMEA Transvenous Market, By Country
      • 9.4.2.2 LAMEA Subcutaneous Market, By Country
    • 9.4.3 LAMEA Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.4.3.1 LAMEA NYHA Class II Market, By Country
      • 9.4.3.2 LAMEA NYHA Class III Market, By Country
    • 9.4.4 LAMEA Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.4.1 LAMEA Hospitals Market, By Country
      • 9.4.4.2 LAMEA Ambulatory Surgical Centers Market, By Country
      • 9.4.4.3 LAMEA Others Market, By Country
    • 9.4.5 LAMEA Implantable Cardioverter Defibrillator Market, By Country
      • 9.4.5.1 Brazil Implantable Cardioverter Defibrillator Market
        • 9.4.5.1.1 Brazil Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.1.2 Brazil Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.1.3 Brazil Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.1.4 Brazil Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.2 Argentina Implantable Cardioverter Defibrillator Market
        • 9.4.5.2.1 Argentina Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.2.2 Argentina Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.2.3 Argentina Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.2.4 Argentina Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.3 UAE Implantable Cardioverter Defibrillator Market
        • 9.4.5.3.1 UAE Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.3.2 UAE Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.3.3 UAE Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.3.4 UAE Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.4 Saudi Arabia Implantable Cardioverter Defibrillator Market
        • 9.4.5.4.1 Saudi Arabia Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.4.2 Saudi Arabia Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.4.3 Saudi Arabia Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.4.4 Saudi Arabia Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.5 South Africa Implantable Cardioverter Defibrillator Market
        • 9.4.5.5.1 South Africa Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.5.2 South Africa Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.5.3 South Africa Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.5.4 South Africa Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.6 Nigeria Implantable Cardioverter Defibrillator Market
        • 9.4.5.6.1 Nigeria Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.6.2 Nigeria Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.6.3 Nigeria Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.6.4 Nigeria Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.7 Rest of LAMEA Implantable Cardioverter Defibrillator Market
        • 9.4.5.7.1 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.7.2 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.7.3 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.7.4 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By End-use

Chapter 10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Segmental and Regional Analysis
    • 10.1.4 Research & Development Expense
    • 10.1.5 Recent strategies and developments:
      • 10.1.5.1 Product Launches and Product Expansions:
      • 10.1.5.2 Trails and Approvals:
    • 10.1.6 SWOT Analysis
  • 10.2 Medtronic PLC
    • 10.2.1 Company overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Segmental and Regional Analysis
    • 10.2.4 Research & Development Expenses
    • 10.2.5 SWOT Analysis
  • 10.3 Biotronik SE & Co. KG
    • 10.3.1 Company Overview
    • 10.3.2 SWOT Analysis
  • 10.4 Boston Scientific Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental and Regional Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 SWOT Analysis
  • 10.5 MicroPort Scientific Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Segmental and Regional Analysis
    • 10.5.4 Research & Development Expense
    • 10.5.5 SWOT Analysis
  • 10.6 Stryker Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expense
    • 10.6.5 Recent strategies and developments:
      • 10.6.5.1 Product Launches and Product Expansions:
    • 10.6.6 SWOT Analysis
  • 10.7 ZOLL Medical Corporation (Asahi Kasei Corporation)
    • 10.7.1 Company Overview
    • 10.7.2 Financial Analysis
    • 10.7.3 Segmental and Regional Analysis
    • 10.7.4 Research & Development Expense
    • 10.7.5 Recent strategies and developments:
      • 10.7.5.1 Acquisition and Mergers:
    • 10.7.6 SWOT Analysis
  • 10.8 LivaNova PLC
    • 10.8.1 Company Overview
    • 10.8.2 Financial Analysis
    • 10.8.3 Segmental and Regional Analysis
    • 10.8.4 Research & Development Expense
    • 10.8.5 SWOT Analysis
  • 10.9 Koninklijke Philips N.V.
    • 10.9.1 Company Overview
    • 10.9.2 Financial Analysis
    • 10.9.3 Segmental and Regional Analysis
    • 10.9.4 Research & Development Expense
    • 10.9.5 Recent strategies and developments:
      • 10.9.5.1 Acquisition and Mergers:
    • 10.9.6 SWOT Analysis
  • 10.10. Getinge AB
    • 10.10.1 Company Overview
    • 10.10.2 Financial Analysis
    • 10.10.3 Segmental and Regional Analysis
    • 10.10.4 Research & Development Expense
    • 10.10.5 SWOT Analysis

Chapter 11. Winning imperatives of Implantable Cardioverter Defibrillator Market

LIST OF TABLES

  • TABLE 1 Global Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 2 Global Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 3 Global Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 4 Global Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 5 Global Biventricular Devices Market, By Region, 2019 - 2022, USD Million
  • TABLE 6 Global Biventricular Devices Market, By Region, 2023 - 2030, USD Million
  • TABLE 7 Global Dual Chamber ICDs Market, By Region, 2019 - 2022, USD Million
  • TABLE 8 Global Dual Chamber ICDs Market, By Region, 2023 - 2030, USD Million
  • TABLE 9 Global Single Chamber ICDs Market, By Region, 2019 - 2022, USD Million
  • TABLE 10 Global Single Chamber ICDs Market, By Region, 2023 - 2030, USD Million
  • TABLE 11 Global Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 12 Global Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 13 Global Transvenous Market, By Region, 2019 - 2022, USD Million
  • TABLE 14 Global Transvenous Market, By Region, 2023 - 2030, USD Million
  • TABLE 15 Global Subcutaneous Market, By Region, 2019 - 2022, USD Million
  • TABLE 16 Global Subcutaneous Market, By Region, 2023 - 2030, USD Million
  • TABLE 17 Global Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 18 Global Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 19 Global NYHA Class II Market, By Region, 2019 - 2022, USD Million
  • TABLE 20 Global NYHA Class II Market, By Region, 2023 - 2030, USD Million
  • TABLE 21 Global NYHA Class III Market, By Region, 2019 - 2022, USD Million
  • TABLE 22 Global NYHA Class III Market, By Region, 2023 - 2030, USD Million
  • TABLE 23 Global Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 24 Global Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 25 Global Hospitals Market, By Region, 2019 - 2022, USD Million
  • TABLE 26 Global Hospitals Market, By Region, 2023 - 2030, USD Million
  • TABLE 27 Global Ambulatory Surgical Centers Market, By Region, 2019 - 2022, USD Million
  • TABLE 28 Global Ambulatory Surgical Centers Market, By Region, 2023 - 2030, USD Million
  • TABLE 29 Global Others Market, By Region, 2019 - 2022, USD Million
  • TABLE 30 Global Others Market, By Region, 2023 - 2030, USD Million
  • TABLE 31 Global Implantable Cardioverter Defibrillator Market, By Region, 2019 - 2022, USD Million
  • TABLE 32 Global Implantable Cardioverter Defibrillator Market, By Region, 2023 - 2030, USD Million
  • TABLE 33 North America Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 34 North America Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 35 North America Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 36 North America Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 37 North America Biventricular Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 38 North America Biventricular Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 39 North America Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 40 North America Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 41 North America Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 42 North America Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 43 North America Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 44 North America Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 45 North America Transvenous Market, By Country, 2019 - 2022, USD Million
  • TABLE 46 North America Transvenous Market, By Country, 2023 - 2030, USD Million
  • TABLE 47 North America Subcutaneous Market, By Country, 2019 - 2022, USD Million
  • TABLE 48 North America Subcutaneous Market, By Country, 2023 - 2030, USD Million
  • TABLE 49 North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 50 North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 51 North America NYHA Class II Market, By Country, 2019 - 2022, USD Million
  • TABLE 52 North America NYHA Class II Market, By Country, 2023 - 2030, USD Million
  • TABLE 53 North America NYHA Class III Market, By Country, 2019 - 2022, USD Million
  • TABLE 54 North America NYHA Class III Market, By Country, 2023 - 2030, USD Million
  • TABLE 55 North America Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 56 North America Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 57 North America Hospitals Market, By Country, 2019 - 2022, USD Million
  • TABLE 58 North America Hospitals Market, By Country, 2023 - 2030, USD Million
  • TABLE 59 North America Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
  • TABLE 60 North America Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
  • TABLE 61 North America Others Market, By Country, 2019 - 2022, USD Million
  • TABLE 62 North America Others Market, By Country, 2023 - 2030, USD Million
  • TABLE 63 North America Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
  • TABLE 64 North America Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
  • TABLE 65 US Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 66 US Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 67 US Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 68 US Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 69 US Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 70 US Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 71 US Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 72 US Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 73 US Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 74 US Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 75 Canada Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 76 Canada Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 77 Canada Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 78 Canada Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 79 Canada Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 80 Canada Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 81 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 82 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 83 Canada Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 84 Canada Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 85 Mexico Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 86 Mexico Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 87 Mexico Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 88 Mexico Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 89 Mexico Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 90 Mexico Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 91 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 92 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 93 Mexico Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 94 Mexico Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 97 Rest of North America Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 101 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 102 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 103 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 104 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 105 Europe Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 106 Europe Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 107 Europe Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 108 Europe Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 109 Europe Biventricular Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Biventricular Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 115 Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 116 Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 117 Europe Transvenous Market, By Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Transvenous Market, By Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Subcutaneous Market, By Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Subcutaneous Market, By Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 122 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 123 Europe NYHA Class II Market, By Country, 2019 - 2022, USD Million
  • TABLE 124 Europe NYHA Class II Market, By Country, 2023 - 2030, USD Million
  • TABLE 125 Europe NYHA Class III Market, By Country, 2019 - 2022, USD Million
  • TABLE 126 Europe NYHA Class III Market, By Country, 2023 - 2030, USD Million
  • TABLE 127 Europe Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 128 Europe Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 129 Europe Hospitals Market, By Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Hospitals Market, By Country, 2023 - 2030, USD Million
  • TABLE 131 Europe Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
  • TABLE 132 Europe Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
  • TABLE 133 Europe Others Market, By Country, 2019 - 2022, USD Million
  • TABLE 134 Europe Others Market, By Country, 2023 - 2030, USD Million
  • TABLE 135 Europe Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
  • TABLE 136 Europe Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
  • TABLE 137 Germany Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 138 Germany Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 139 Germany Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 140 Germany Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 141 Germany Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 142 Germany Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 143 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 144 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 145 Germany Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 146 Germany Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 147 UK Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 148 UK Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 149 UK Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 150 UK Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 151 UK Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 152 UK Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 153 UK Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 154 UK Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 155 UK Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 156 UK Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 157 France Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 158 France Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 159 France Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 160 France Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 161 France Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 162 France Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 163 France Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 164 France Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 165 France Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 166 France Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 167 Russia Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 168 Russia Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 169 Russia Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 170 Russia Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 171 Russia Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 172 Russia Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 173 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 174 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 175 Russia Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 176 Russia Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 177 Spain Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 178 Spain Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 179 Spain Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 180 Spain Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 181 Spain Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 182 Spain Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 183 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 184 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 185 Spain Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 186 Spain Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 187 Italy Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 188 Italy Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 189 Italy Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 190 Italy Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 191 Italy Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 192 Italy Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 193 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 194 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 195 Italy Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 196 Italy Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 197 Rest of Europe Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 198 Rest of Europe Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 199 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 200 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 201 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 202 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 203 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 204 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 205 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 206 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Biventricular Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Biventricular Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Transvenous Market, By Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Transvenous Market, By Country, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Subcutaneous Market, By Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Subcutaneous Market, By Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 225 Asia Pacific NYHA Class II Market, By Country, 2019 - 2022, USD Million
  • TABLE 226 Asia Pacific NYHA Class II Market, By Country, 2023 - 2030, USD Million
  • TABLE 227 Asia Pacific NYHA Class III Market, By Country, 2019 - 2022, USD Million
  • TABLE 228 Asia Pacific NYHA Class III Market, By Country, 2023 - 2030, USD Million
  • TABLE 229 Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 230 Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 231 Asia Pacific Hospitals Market, By Country, 2019 - 2022, USD Million
  • TABLE 232 Asia Pacific Hospitals Market, By Country, 2023 - 2030, USD Million
  • TABLE 233 Asia Pacific Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
  • TABLE 234 Asia Pacific Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
  • TABLE 235 Asia Pacific Others Market, By Country, 2019 - 2022, USD Million
  • TABLE 236 Asia Pacific Others Market, By Country, 2023 - 2030, USD Million
  • TABLE 237 Asia Pacific Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
  • TABLE 238 Asia Pacific Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
  • TABLE 239 China Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 240 China Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 241 China Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 242 China Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 243 China Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 244 China Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 245 China Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 246 China Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 247 China Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 248 China Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 249 Japan Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 250 Japan Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 251 Japan Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 252 Japan Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 253 Japan Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 254 Japan Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 255 Japan Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 256 Japan Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 257 Japan Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 258 Japan Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 259 India Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 260 India Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 261 India Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 262 India Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 263 India Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 264 India Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 265 India Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 266 India Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 267 India Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 268 India Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 269 South Korea Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 270 South Korea Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 271 South Korea Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 272 South Korea Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 273 South Korea Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 274 South Korea Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 275 South Korea Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 276 South Korea Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 277 South Korea Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 278 South Korea Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 279 Singapore Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 280 Singapore Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 281 Singapore Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 282 Singapore Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 283 Singapore Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 284 Singapore Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 285 Singapore Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 286 Singapore Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 287 Singapore Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 288 Singapore Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 289 Malaysia Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 290 Malaysia Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 291 Malaysia Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 292 Malaysia Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 293 Malaysia Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 294 Malaysia Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 295 Malaysia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 296 Malaysia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 297 Malaysia Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 298 Malaysia Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 299 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 300 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 301 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 302 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 303 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 304 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 305 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 306 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 307 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 308 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million